Page last updated: 2024-09-04

cyc 202 and Recrudescence

cyc 202 has been researched along with Recrudescence in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, CE; Edwards, J; Fyffe, G; Heng, SJ; Horgan, PG; Leung, HY; McCall, P; Seywright, M; Tannahill, C; Underwood, MA; Willder, JM1

Other Studies

1 other study(ies) available for cyc 202 and Recrudescence

ArticleYear
Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients.
    British journal of cancer, 2013, Jan-15, Volume: 108, Issue:1

    Topics: Aged; Biomarkers, Tumor; CDC2 Protein Kinase; Disease-Free Survival; Humans; Male; MAP Kinase Signaling System; Phosphorylation; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Purines; Receptors, Androgen; Recurrence; Roscovitine; Serine

2013